Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.

Ambrish Singh,Debashish Danda,Salman Hussain,Abul Kalam Najmi,Ashish J. Mathew,Ruchika Goel,Shaheen E. Lakhan,Belzik Tajudheen,Benny Antony

Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.

2020

Ambrish Singh
Debashish Danda
Salman Hussain
Abul Kalam Najmi
Ashish J. Mathew
Ruchika Goel
Shaheen E. Lakhan
Belzik Tajudheen
Benny Antony

AbstractBackground: Takayasu arteritis (TAK) is a chronic immune vasculitis in which Interleukin-6 (IL-6) receptors play a key role in pathogenesis. Tocilizumab (TCZ), an IL-6 receptor antagonist w...

Keywords:

Tocilizumab
Gastroenterology
Vasculitis
Medicine
Large vessel vasculitis
Pathogenesis
Receptor antagonist
Arteritis
Internal medicine
Randomized controlled trial
Immune system
Physical therapy
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations